Spotlight

Mission
Impact Journals will be hosting both video and written interviews designed to highlight some of the world’s leading researchers and their institutions. This content will bring forth interesting aspects of biomedical research, and will provide useful advice for young postdocs seeking to make advances in their fields.

Behind the Study: Retaining Nanomolar Potency in Lung Cancer

Oncotarget

August 16, 2021
Dr. Aditya Kulkarni discusses a study he co-authored, published by Oncotarget in 2021, and entitled, “The acylfulvene alkylating agent, LP-184, retains nanomolar potency in non-small cell lung cancer carrying otherwise therapy-refractory mutations.” continue reading »

Behind the Study: COVID-19 Affect on Elderly

Aging

August 2, 2021
Dr. David Sinclair from Harvard Medical School and member of the Aging Editorial Board details his review published by Aging on May 29, 2020, entitled, “Why does COVID-19 disproportionately affect older people?“ continue reading »

Behind the Study: Cdkn1a Transcript and Aging

Aging

July 26, 2021
Dr. Judith Campisi discusses her priority research paper published in 2021 by Aging, entitled, "Cdkn1a transcript variant 2 is a marker of aging and cellular senescence." continue reading »

Behind the Study: COVID-19 and Chronological Aging

Aging

July 19, 2021
Dr. Michael Lisanti describes his 2020 paper published by Aging, entitled, "COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?" continue reading »

Behind the Study: ONC201, TRAIL, and Breast Cancer

Oncotarget

July 5, 2021
Founding Oncotarget Editorial Board Member, Dr. Wafik S. El-Deiry, and recent MD/PhD graduate of Temple University, Dr. Marie D. Ralff, discuss their 2020 paper: “TRAIL receptor agonists convert the response of breast cancer cells to ONC201 from anti-proliferative to apoptotic.” continue reading »